Products
Anoro
(umeclidinium/vilanterol inhalation powder)
Arexvy
(Respiratory Syncytial Virus vaccine recombinant, adjuvanted)
Avamys
(fluticasone furoate)
Dovato
(dolutegravir/lamivudine)
Imigran
(sumatriptan)
Incruse
(umeclidinium bromide)
Nucala
(mepolizumab)
Omjjara
(momelotinib)
Relvar Ellipta
(fluticasone furoate/vilanterol)
Rotarix
(rotavirus vaccine)
Shingrix
Herpes zoster vaccine (recombinant, adjuvanted)
Tivicay
(dolutegravir)
Trelegy Ellipta
(fluticasone furoate/umeclidinium/vilanterol)
Triumeq
(dolutegravir/abacavir/lamivudine)
Vocabria
(cabotegravir)
Vocabria
(cabotegravir) | VOCABRIA (cabotegravir) prolonged-release suspension for injection should always be prescribed with REKAMBYS
Volibris
(ambrisentan)
Zyban
(bupropion hydrochloride)
Zejula
(niraparib tosylate monohydrate)
oncology
Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
Trade marks are owned by or licensed to the GSK group of companies.